Susquehanna International Group, LLP Inovio Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.35 - $0.53 $42,759 - $64,750	122,171 Added 72.86%	289,840 $147,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $224,102 - $342,051	-589,744 Reduced 77.86%	167,669 $65,000
Q2 2023 Aug 11, 2023	SELL	$0.39 - $0.94 $45,134 - $108,786	-115,730 Reduced 13.25%	757,413 $340,000
Q1 2023 May 16, 2023	BUY	$0.79 - $1.91 $282,038 - $681,891	357,011 Added 69.17%	873,143 $715,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $727,980 - $1.29 Million	-516,298 Reduced 50.01%	516,132 $805,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $439,144 - $738,080	264,545 Added 34.45%	1,032,430 $1.78 Million
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.98 $923,340 - $2.55 Million	-641,209 Reduced 45.51%	767,885 $1.33 Million
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $1.61 Million - $2.82 Million	-543,112 Reduced 27.82%	1,409,094 $5.06 Million
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $1.03 Million - $1.54 Million	206,067 Added 11.8%	1,952,206 $9.74 Million
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $1.98 Million - $2.67 Million	275,993 Added 18.77%	1,746,139 $12.5 Million
Q2 2021 Aug 11, 2021	BUY	$6.23 - $10.03 $3.39 Million - $5.45 Million	543,808 Added 58.71%	1,470,146 $13.6 Million
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $1.04 Million - $2 Million	117,638 Added 14.55%	926,338 $8.6 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $720,230 - $1.09 Million	84,733 Added 11.7%	808,700 $7.16 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $1.86 Million - $5.26 Million	194,626 Added 36.77%	723,967 $8.4 Million
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $5.4 Million - $24 Million	-755,879 Reduced 58.81%	529,341 $14.3 Million
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $3.71 Million - $17.5 Million	1,243,484 Added 2979.4%	1,285,220 $9.56 Million
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $88,808 - $130,829	-43,321 Reduced 50.93%	41,736 $86,000
Q2 2019 Aug 16, 2019	BUY	$2.29 - $4.1 $26,671 - $47,752	11,647 Added 15.87%	85,057 $250,000
Q2 2019 Aug 14, 2019	BUY	$2.29 - $4.1 $143,024 - $256,069	62,456 Added 570.17%	73,410 $216,000
Q4 2018 Feb 14, 2019	SELL	$3.89 - $6.11 $16,092 - $25,277	-4,137 Reduced 27.41%	10,954 $44,000
Q3 2018 Nov 14, 2018	SELL	$3.92 - $5.58 $260,625 - $370,991	-66,486 Reduced 81.5%	15,091 $84,000
Q2 2018 Aug 14, 2018	SELL	$3.88 - $5.16 $57,152 - $76,006	-14,730 Reduced 15.29%	81,577 $320,000
Q4 2017 Feb 14, 2018	BUY	$4.13 - $6.68 $351,004 - $567,726	84,989 Added 750.92%	96,307 $398,000
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $60,664 - $72,095	11,318	11,318 $72,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account